搜索临床试验以:Anti-PD-1/PD-L1
总计5783个结果
-
Centre Leon BerardNETRIS Pharma招聘中
-
Tongji HospitalNational Natural Science Foundation of China招聘中
-
Chinese PLA General HospitalLinkDoc Technology (Beijing) Co. Ltd.未知
-
Second Affiliated Hospital of Soochow University尚未招聘
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)完全的
-
Hoffmann-La Roche完全的
-
University Hospital, Bordeaux招聘中在使用 PD1/PDL1 ICIs + VEGFR-酪氨酸激酶抑制剂治疗 12 个月时有客观反应的 mRCC 患者中只有一个不良预后因素的 IMDC 良好或中等风险的治疗暂停与治疗继续 (SPICI)转移性肾细胞癌 | 每个 IMDC 评分的良好或只有一个不良预后因素中等风险法国
-
Second Affiliated Hospital of Soochow UniversitySciClone Pharmaceuticals招聘中
-
Tongji HospitalWuhan University; Sun Yat-sen University; Wuhan Union Hospital, China暂停
-
Second Affiliated Hospital, School of Medicine,...Westlake Therapeutics招聘中
-
Vestre Viken Hospital TrustOslo University Hospital; University Hospital of North Norway; Helse Stavanger HF; Haukeland University... 和其他合作者招聘中
-
Shanghai Huaota Biopharmaceutical Co., Ltd.招聘中
-
Jason J. Luke, MD招聘中黑色素瘤 | 宫颈癌 | 肝细胞癌 | 胃癌 | 大肠癌 | 非小细胞肺癌 | 晚期实体瘤 | 胆管癌 | 膀胱癌 | 肾癌 | 肛门癌 | 默克尔细胞癌 | HNSCC美国
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdSunshine Lake Pharma Co., Ltd.终止
-
Pharmassist LtdUniversity of Athens主动,不招人
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中